Allspring Global Investments Holdings, LLC Nuvation Bio Inc. Transaction History

Allspring Global Investments Holdings, LLC

  • $62.1 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 18, 2023
SELL
$1.56 - $1.84 $1,285 - $1,516
-824 Reduced 63.48%
474 $0
Q1 2023

Apr 13, 2023
BUY
$1.6 - $2.48 $1,662 - $2,576
1,039 Added 401.16%
1,298 $2,000
Q4 2022

Jan 23, 2023
BUY
$1.68 - $2.5 $435 - $647
259 New
259 $0
Q2 2022

Jul 25, 2022
SELL
$3.24 - $5.85 $256,633 - $463,366
-79,208 Closed
0 $0
Q1 2022

May 02, 2022
BUY
$4.6 - $8.83 $113,647 - $218,153
24,706 Added 45.33%
79,208 $416,000
Q4 2021

Jan 28, 2022
BUY
$7.75 - $10.05 $422,390 - $547,745
54,502 New
54,502 $463,000

Others Institutions Holding NUVB

# of Institutions
152
Shares Held
123M
Call Options Held
9.7K
Put Options Held
6.5K
View Full List

About Nuvation Bio Inc.

NUVB Quotes by TradingView
  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $480M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email